Overview
This study aims to synthesise PET data that preserves biological relevance and adds clinical value to the diagnosis and prognosis of lung cancer by establishing anatomical-to-metabolic mapping based on paired diagnostic CT and FDG-PET scans, thereby prospectively validating the clinical utility of the model.
Eligibility
Inclusion Criteria:
- Patients with non-small cell lung cancer scheduled to undergo PET-CT and pathological examinations;
- Voluntarily participate and sign an informed consent form;
Exclusion Criteria:
- History of other malignant tumours;
- Image artefacts;
- Without pathological diagnostic information;
- Without paired CT and FDG-PET scan images.